SELLAS Life Sciences (SLS) FCF Payout Ratio (2018)

SELLAS Life Sciences (SLS) posted quarterly FCF Payout Ratio of 0.03 for Q3 2018.

SELLAS Life Sciences (SLS) FCF Payout Ratio (2018) Analysis & Trends

SELLAS Life Sciences (SLS) has reported FCF Payout Ratio for 1 consecutive years, with 0.03 the latest figure, recorded in Q3 2018.

In Q3 2018, FCF Payout Ratio changed N/A year-over-year to 0.03; the TTM figure through Dec 2019 stood at 0.02 (down 72.43% YoY), while the FY2018 annual figure was 0.02, changed N/A from the prior year.
FCF Payout Ratio held at 0.03 in Q3 2018 per SLS's latest filing.
Across five years, FCF Payout Ratio topped out at 0.03 in Q3 2018 and bottomed at 0.03 in Q3 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Cover (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	0.17
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	0.07
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	SELLAS Life Sciences	2.32 Bn	2.18 Bn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2018	-0.03